Evidence map›Paper›PMID 36907331›Full record

ArticleVirologica Sinica2023

Transcriptome analysis of CD4

Jingliang Chen, Yaozu He, Huolin Zhong, Fengyu Hu, Yonghong Li, Yeyang Zhang, Xia Zhang, Weiyin Lin, Quanmin Li, Feilong Xu and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Virologica Sinica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Signal integrator function of CXXC5 in Cancer.Cell communication and signaling : CCS · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Jingliang ChenGuangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510060, China.
Yaozu HeGuangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510060, China.
Huolin ZhongGuangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510060, China.
Fengyu HuGuangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510060, China.
Yonghong LiGuangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510060, China.
Yeyang ZhangGuangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510060, China.
Xia ZhangGuangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510060, China.
Weiyin LinGuangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510060, China.
Quanmin LiGuangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510060, China.
Feilong XuGuangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510060, China.
Shaozhen ChenGuangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510060, China.
Hui ZhangInstitute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China; Guangzhou Laboratory, Bio-Island, Guangzhou, 510320, China. Electronic address: zhangh92@mail.sysu.edu.cn.
Weiping CaiGuangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510060, China. Electronic address: gz8hcwp@126.com.
Linghua LiGuangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510060, China. Electronic address: llheliza@126.com.
Guangzhou Eighth People's Hospital · CNGuangzhou Medical University · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Some HIV-infected individuals receiving ART develop low-level viremia (LLV), with a plasma viral load of 50-1000 copies/mL. Persistent low-level viremia is associated with subsequent virologic failure. The peripheral blood CD4

Indexed as

Anti-HIV AgentsHIV-1HIV InfectionsHIV SeropositivityCD4-Positive T-LymphocytesDNA-Binding ProteinsGene Expression ProfilingHumansT-LymphocytesTranscription FactorsViral LoadViremiaAnti-HIV AgentsCXXC5 protein, humanDNA-Binding ProteinsTranscription FactorsCXXC5HIV-1HIV-1 promoterLow-level viremia (LLV)SOX5Transcriptome

Identifiers

PMID36907331
PMCPMC10311176
OpenAlexW4323817180

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.